Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Nics

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Psychoneuroendocrinology|August 20, 2021
High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary reportGeorg S Kranz, Marie Spies, Chrysoula Vraka, et al.
Neuroimage|March 16, 2023
Whole-body metabolic connectivity framework with functional PETMurray Bruce Reed, Magdalena Ponce de León, Chrysoula Vraka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliabilityIrena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
EJNMMI Research|August 26, 2022
Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[<sup>11</sup>C]Me-NB1Lucas Rischka, Matej Murgaš, Verena Pichler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2021
First-in-Humans Brain PET Imaging of the GluN2B-Containing <i>N</i>-methyl-d-aspartate Receptor with (<i>R</i>)-<sup>11</sup>C-Me-NB1Lucas Rischka, Chrysoula Vraka, Verena Pichler, et al.
Journal of Affective Disorders|June 23, 2025
Phenotyping extracellular vesicles and their serotonin transporter cargo in major depressive disorderŁukasz Zadka, Benjamin Eggerstorfer, Igor Buzalewicz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 26, 2018
Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivoGregory M James, Gregor Gryglewski, Thomas Vanicek, et al.
Translational Psychiatry|September 23, 2018
Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapyMarie Spies, Gregory M James, Chrysoula Vraka, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2025
Connecting the dots: approaching a standardized nomenclature for molecular connectivity in positron emission tomographyMurray B Reed, Luca Cocchi, Christin Y Sander, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Psychoneuroendocrinology|August 20, 2021
High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary reportGeorg S Kranz, Marie Spies, Chrysoula Vraka, et al.
Neuroimage|March 16, 2023
Whole-body metabolic connectivity framework with functional PETMurray Bruce Reed, Magdalena Ponce de León, Chrysoula Vraka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliabilityIrena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
EJNMMI Research|August 26, 2022
Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[<sup>11</sup>C]Me-NB1Lucas Rischka, Matej Murgaš, Verena Pichler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2021
First-in-Humans Brain PET Imaging of the GluN2B-Containing <i>N</i>-methyl-d-aspartate Receptor with (<i>R</i>)-<sup>11</sup>C-Me-NB1Lucas Rischka, Chrysoula Vraka, Verena Pichler, et al.
Journal of Affective Disorders|June 23, 2025
Phenotyping extracellular vesicles and their serotonin transporter cargo in major depressive disorderŁukasz Zadka, Benjamin Eggerstorfer, Igor Buzalewicz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 26, 2018
Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivoGregory M James, Gregor Gryglewski, Thomas Vanicek, et al.
Translational Psychiatry|September 23, 2018
Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapyMarie Spies, Gregory M James, Chrysoula Vraka, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2025
Connecting the dots: approaching a standardized nomenclature for molecular connectivity in positron emission tomographyMurray B Reed, Luca Cocchi, Christin Y Sander, et al.
Pageof 9